Characterization and activity test of commercial Ni/Al2O3, Cu/ZnO/Al2O3 and prepared NieCu/Al2O3 catalysts for hydrogen production from methane and methanol fuels

In this study, methane and methanol steam reforming reactions over commercial Ni/Al2O3, commercial Cu/ZnO/Al2O3 and prepared NieCu/Al2O3 catalysts were investigated. Methane and methanol steam reforming reactions catalysts were characterized using various techniques. The results of characterization showed that Cu particles increase the active particle size of Ni (19.3 nm) in NieCu/Al2O3 catalyst with respect to the commercial Ni/ Al2O3 (17.9). On the other hand, Ni improves Cu dispersion in the same catalyst (1.74%) in comparison with commercial Cu/ZnO/Al2O3 (0.21%). A comprehensive comparison between these two fuels is established in terms of reaction conditions, fuel conversion, H2 selectivity, CO2 and CO selectivity. The prepared catalyst showed low selectivity for CO in both fuels and it was more selective to H2, with H2 selectivities of 99% in methane and 89% in methanol reforming reactions. A significant objective is to develop catalysts which can operate at lower temperatures and resist deactivation. Methanol steam reforming is carried out at a much lower temperature than methane steam reforming in prepared and commercial catalyst (275-325 o C). However, methane steam reforming can be carried out at a relatively low temperature on NieCu catalyst (600-650 o C) and at higher temperature in commercial methane reforming catalyst (700-800 o C). Commercial Ni/Al2O3 catalyst resulted in high coke formation (28.3% loss in mass) compared to prepared NieCu/Al2O3 (8.9%) and commercial Cu/ZnO/Al2O3 catalysts (3.5%).Web of Scienc

A Preliminary Report Regarding the Morphological Changes of Nano-Enabled Pharmaceutical Formulation on Human Lung Carcinoma Monolayer and 3D Bronchial Microtissue

Background and Objectives: Nowadays, the development of enabled pharmaceutical nanoparticles of solid lipid type is continuously growing, because they have the potential to be used for targeted drug release leading to an increased effect of chemotherapy, being used in lung cancer nano-diagnosis and nano-therapy. The current study reports the preliminary results obtained regarding the biological effect of a new nano-enabled pharmaceutical formulation in terms of its cytotoxic and biosafety profile. Materials and Methods: The pharmaceutical formulations consist of solid lipid nanoparticles (SLN) obtained via the emulsification–diffusion method by loading green iron oxide nanoparticles (green-IONPs) with a pentacyclic triterpene (oleanolic acid—OA). Further, a complex biological assessment was performed, employing three-dimensional (3D) bronchial microtissues (EpiAirwayTM) to determine the biosafety profile of the SLN samples. The cytotoxic potential of the samples was evaluated on human lung carcinoma, using an in vitro model (A549 human lung carcinoma monolayer). Results: The data revealed that the A549 cell line was strongly affected after treatment with SLN samples, especially those that contained OA-loaded green-IONPs obtained with Ocimum basilicum extract (under 30% viability rates). The biosafety profile investigation of the 3D normal in vitro bronchial model showed that all the SLN samples negatively affected the viability of the bronchial microtissues (below 50%). As regards the morphological changes, all the samples induce major changes such as loss of the surface epithelium integrity, loss of epithelial junctions, loss of cilia, hyperkeratosis, and cell death caused by apoptosis. Conclusions: In summary, the culprit for the negative impact on viability and morphology of 3D normal bronchial microtissues could be the too-high dose (500 µg/mL) of the SLN sample used. Nevertheless, further adjustments in the SLN synthesis process and another complex in vitro evaluation will be considered for future research

Evaluating the Connection between MicroRNAs and Long Non-Coding RNAs for the Establishment of the Major Depressive Disorder Diagnosis

The most prevalent mental illness worldwide and the main contributor to suicide and disability is major depressive disorder. Major depressive disorder is now diagnosed and treated based on the patient’s statement of symptoms, mental status tests, and clinical behavioral observations. The central element of this review is the increased need for an accurate diagnostic method. In this context, the present research aims to investigate the potential role of two non-coding RNA species (microRNA and long non-coding RNA) in peripheral blood samples and brain tissue biopsy from patients with major depressive disorder. This study reviewed the literature on microRNA and long non-coding RNA expression in blood and brain tissue samples in human and animal depression models by retrieving relevant papers using the PubMed database. The results reveal significant variations in microRNA and long non-coding RNA levels in depressed patients, making it a crucial diagnostic tool that predicts treatment outcomes. It can help track severe cases and adjust therapy dosages based on treatment responses. In conclusion, microRNAs and long non-coding RNAs are pertinent biomarkers that can be added to the diagnostic test panel for major depressive disorder. Both microRNAs and non-coding RNAs can also be used as a tool to track patient progress during therapy and to assist the attending physician in tracking the molecular development of the disease

Operating strategies for fuel processing systems with a focus on water–gas shift reactor stability

This contribution deals with the development of suitable operating strategies for diesel/kerosene-fueled fuel cell APUs. The focus is on the autothermal reformer (ATR) and the water–gas shift (WGS) reactor. In the first part shutdown experiments under high-temperature shift (HTS) conditions were used to identify the possible detrimental effect of higher hydrocarbons on the activity and stability of two commercial WGS catalysts. The results indicated that 220 ppmv higher hydrocarbons had no negative effect on the catalyst activity/stability. The second part presents fuel processing system experiments, which revealed much higher concentrations of higher hydrocarbons during transients like startup/shutdown than the concentrations investigated in the first part. Through the development of new startup/shutdown strategies concentrations of higher hydrocarbons were lowered by a factor of up to 10 for startup and of up to 400 for shutdown. The results were reproduced using four different diesel and kerosene fuels. The newly developed strategies improve fuel conversion in the reformer and may possibly prevent catalyst deactivation in the water–gas shift reactor during transient conditions